CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Smart Money VCs (6326) Pharma Startups (6570) Cancer Therapeutics (1180)
Verastem is a biopharmaceutical company focused on discovering and developing drugs that selectively target cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is translating breakthrough discover...Show all
Company (IPO / Went public)
Phone:
215 First Street
Suite 440
Cambridge, 02142
Massachusetts, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Methods and compositions for treating abnormal cell growth | Feb 06, 2015 | May 08, 2018 | Patent |
| Synthesis and use of kinase inhibitors | Aug 07, 2013 | Nov 29, 2016 | Patent |
| Oral formulations of kinase inhibitors | Aug 14, 2013 | Jun 28, 2016 | Patent |
| Pyrimidine derivatives for the treatment of abnormal cell growth | Nov 20, 2006 | May 13, 2014 | Patent |
| Pyrimidine substituted purine derivatives | Jul 20, 2012 | Dec 17, 2013 | Patent |
